ADA Scientific Sessions 2026 Abstract

Gut Microbiota–Driven GLP-1 Signaling Defects Underlie Metformin Nonresponsiveness and Are Reversible with Probiotic Therapy

By Sidharth P. Mishra

Experiments in animalsInterventions

The paper

Sidharth P. Mishra

Tampa

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, late-breaking 2873-LB

doi.org/10.2337/db26-2873-lb

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Research Square8 Oct 2026
Semaglutide improved heart artery function in pigs